Diaa Diab

• Developed and executed medical affairs training strategy and tactical plans for complementmediated rare diseases (Heme & Neph).
• Spearheaded the development and implementation of comprehensive training programs for Heme & Neph rare diseases to enhance team expertise and launch readiness.
• Led the GTAC (Global Training Committee) team to align global medical efforts across clinical, regulatory, commercial, and medical communications to achieve company strategy.
• Introduced innovative training methods to address diverse field needs and knowledge gaps while promoting a culture of continuous learning such as omnichannel e-learning, bootcamps, and expert-led sessions, to enhance field teams' disease knowledge and readiness.
• Validated compliance and MLR approval of training resources & materials for key projects and initiatives, enhancing overall training project integrity.
• Designed and implemented a comprehensive MSL scientific onboarding program, including version control and certification processes. Developed and updated both general and publication-specific materials to ensure consistent, current information delivery.
• Spearheaded MSL competitive readiness through SWOT analysis workshops, addressing field challenges and managing complex inquiries.
• Executed customized deep dive workshops for China, International, and expansion markets, effectively addressing specific needs and closing knowledge gaps to overcome field challenges.
• Integrated CRM and Power BI to enhance data visualization and address field gaps, optimizing training programs, onboarding, and professional development initiatives.
• Enhancement of MSL onboarding through integration of MindTickle and DEGREED platforms for more efficient learning experience.
• Developed a disease narrative to equip MSLs with aligned scientific messages and lead training on expanding treatment for challenging patient segments.

• Led global medical strategy development for Myasthenia Gravis (MG) and NMO (Neuro Myelitis Optica).
• Supported research gap analysis and long-term evidence generation planning.
• Developed publication strategies and congress activities with GMA objectives in collaboration with Sci Com.
• Led Neurology MSLs' launch preparedness in US, Germany, and Japan, overseeing training, KOL mapping, advisory boards, and addressing knowledge gaps for strategic market entry.
• Orchestrated the successful global launch strategy for Myasthenia Gravis, achieving market entry in the USA, Germany, and Japan.
• Built and leveraged strong professional relationships with KOLs and external scientific advisors to enhance strategic influence and drive collaborative initiatives.

• Established the business presence in the MENA region by driving pre-launch and launch activities for nephrology and hematology products.
• Led the Medical Affairs team, including MSLs, in the MENA region to enhance field operations and strategic alignment, successfully driving pre-launch and launch activities in nephrology and hematology, conducting competitive readiness workshops, and establishing robust business and stakeholder engagement.
• Oversaw compliance monitoring, pharmacovigilance, patient management, and lab development training for diagnostic personnel.
• Organized advisory boards, roadshows, speaker tours, and regional clinical trials to support strategic objectives.
• Launched Eculizumab educational awareness campaigns in Nephrology and Hematology.
• Rolled out diagnostic projects and compliance programs across the MENA region.
• Developed high-performing teams by providing mentorship, guidance, and opportunities for professional growth.
• Cultivated a positive work environment that fostered employee engagement, increased retention rates, and boosted overall team morale.

• Led the successful launch of two new enzyme replacement therapy products in the MENA region, while effectively managing relationships with key opinion leaders (KOLs) and coordinating advisory boards to drive product adoption and awareness

• Led comprehensive clinical trial management, including streamlining documentation processes, maintaining master files, and ensuring regulatory compliance across multiple Middle Eastern and Gulf regions
• Secured successful regulatory approvals and pharmacovigilance activities, overseeing local authority reporting and collaborating with global teams to enhance safety monitoring and reporting efficiency
• Conducted and managed scientific and sales training programs for field-facing teams, significantly improving their performance and capabilities in enzyme replacement therapy, and hemato-oncology.

• Led phase III clinical trials across Gulf region, elevating center standards and delivering GCP training to enable Roche's research expansion.
• Developed targeted training for medical and commercial teams, enhancing product knowledge and communication to boost market performance.
• Cultivated key oncology KOL relationships, leveraging expertise to inform strategy and elevate scientific reputation.
• Crafted scientific communications, delivering post-congress updates and refining content to solidify oncology leadership position.